lansoprazole has been researched along with Weight Loss in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Weight Loss: Decrease in existing BODY WEIGHT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melissas, J | 1 |
| Kampitakis, E | 1 |
| Schoretsanitis, G | 1 |
| Mouzas, J | 1 |
| Kouroumalis, E | 1 |
| Tsiftsis, DD | 1 |
1 other study available for lansoprazole and Weight Loss
| Article | Year |
|---|---|
Does reduction in gastric acid secretion in bariatric surgery increase diet-induced thermogenesis?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Calorimetry; Diet; Digestion; Fem | 2002 |